Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Spine (Phila Pa 1976). 2013 Jan 1;38(1):11-6. doi: 10.1097/BRS.0b013e3182610fa9.
Immunohistological analysis of spinal glial cells and analysis of pain behavior in the rat neuropathic pain model were investigated to clarify the function of tumor necrosis factor (TNF)-α receptors p55 type 1 and p75 type 2.
Our objective was to investigate changes in hyperalgesia and glial cell activation after injection of antibodies to each TNF receptor in a rat sciatic nerve injury model.
Recent research has revealed that activation of spinal glia plays an important role in radicular and neuropathic pain. TNF-α is reportedly a modulator for glial cell activation; however, the precise relationship between TNF-α and its 2 receptors on glial cells has not been fully delineated.
Chronic constriction sciatic nerve injury and sham-operated rats were used. Antibodies to p55 or p75 or saline were intrathecally injected at the L5 level into rats with chronic constriction injury. Mechanical allodynia was examined for 2 weeks. Spinal cords were removed for immunohistochemical studies of ionized calcium-binding adaptor molecule 1 or glial fibrillary acidic protein.
Saline rats showed significantly more mechanical allodynia and the number of ionized calcium-binding adaptor molecule 1--immunoreactive microglia and glial fibrillary acidic protein--immunoreactive astrocytes were significantly increased in the saline rats compared with sham-operated rats during the 2 weeks. Injection of both antibodies significantly reduced pain behavior and anti-p55 caused significantly greater reduction compared with anti-p75. The numbers of microglia in both the antibodies groups were significantly decreased when compared with the saline group. In addition, the anti-p55 antibody suppressed microglial activation more than the anti-p75 antibody.
These results indicate that the microglial TNF-α p55 pathway played a more important role than the TNF-α p75 pathway in the pathogenesis of peripheral nerve injury pain. This suggests that future studies seeking to clarify neuropathic pain should target TNF-α and p55 receptors in microglia.
通过对脊髓神经胶质细胞的免疫组化分析以及对大鼠神经病理性疼痛模型的疼痛行为分析,来阐明肿瘤坏死因子(TNF)-α受体 p55 型 1 和 p75 型 2 的功能。
我们的目的是研究在大鼠坐骨神经损伤模型中,注射每种 TNF 受体抗体后,痛觉过敏和神经胶质细胞激活的变化。
最近的研究表明,脊髓神经胶质细胞的激活在神经根性和神经病理性疼痛中起着重要作用。据报道,TNF-α是神经胶质细胞激活的调节剂;然而,TNF-α与其在神经胶质细胞上的 2 种受体之间的确切关系尚未完全阐明。
采用慢性缩窄性坐骨神经损伤和假手术大鼠。将 p55 或 p75 抗体或生理盐水鞘内注射到慢性缩窄性损伤大鼠的 L5 水平。检测机械性痛觉过敏 2 周。取出脊髓进行离子钙结合衔接分子 1 或胶质纤维酸性蛋白的免疫组织化学研究。
与假手术大鼠相比,生理盐水大鼠在 2 周内表现出明显更明显的机械性痛觉过敏,并且生理盐水大鼠的离子钙结合衔接分子 1 免疫反应性小胶质细胞和胶质纤维酸性蛋白免疫反应性星形胶质细胞的数量明显增加。两种抗体的注射均显著减轻疼痛行为,且抗 p55 引起的疼痛行为减轻程度明显大于抗 p75。与生理盐水组相比,两种抗体组的小胶质细胞数量均明显减少。此外,抗 p55 抗体对小胶质细胞的激活抑制作用强于抗 p75 抗体。
这些结果表明,在周围神经损伤性疼痛的发病机制中,小胶质细胞 TNF-α p55 途径比 TNF-α p75 途径更为重要。这表明,未来旨在阐明神经病理性疼痛的研究应针对小胶质细胞中的 TNF-α 和 p55 受体。